×
Ionis CS5 GOLDEN

Ionis CS5 GOLDEN

A Phase 2, Randomized, Placebo-Controlled, Double-Masked Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRX, and Antisense Inhibitor of Complement Factor B, in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration.

Principal Investigator – Dr. Fred Chen

For further information contact the Clinical Trials Office on (08) 9381 0750 or email clinicalresearch@lei.org.au

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Request an appointment